Studies have shown that estrogen may decrease the risk of HCC by decreasing the levels of pro‐inflammatory mediators, such as IL‐6, androgens and vascular endothelial growth factor, which may decrease the progression to HCC.130. This evidence concerns the gene VEGFA and hepatocellular carcinoma.